У нас вы можете посмотреть бесплатно The Great TB Debate: Can We Cure Tuberculosis by Engineering the Host? или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
The Great TB Debate: Can We Cure Tuberculosis by Engineering the Host? #tb #autophagy #metformin Is it time to stop attacking the bacteria and start upgrading the human? Tuberculosis (TB) remains the world’s deadliest bacterial infection, but traditional antibiotics are hitting a wall of multidrug resistance (MDR-TB). Join us for a high-stakes debate as we explore the revolutionary shift toward Host-Directed Therapy (HDT)—a "Precision Engineering" approach that re-wires your immune system to win the fight from the inside. In this debate, we tackle the big questions: Repurposing vs. Innovation: Should we recycle old drugs like Metformin to reduce lung damage, or design brand-new "smart molecules" like SMIP-031 to flip the master switch of cellular defense. The Hidden Enemy: We reveal the discovery of MNC1 lung cells—the "lysosome-poor" hideouts where TB bacteria persist during chronic infection—and how drugs like Nilotinib can re-arm them. The Survival Switch: Watch the experts clash over the TFEB-Autophagy axis, the body’s internal incinerator that can be activated to "digest" even the most resistant strains of TB. Oral vs. Inhalable: Is the future a pill or a puff? We discuss the breakthrough of inhalable β-glucan microparticles that deliver medication with pinpoint accuracy directly to the lungs. Why this matters: Traditional therapy acts like a wrecking ball; Precision Host-Directed Engineering acts like an electrician fixing the building's security system. This strategy could shorten treatment times, prevent permanent lung scarring (PTLD), and finally end the TB epidemic. . Who wins the debate? Watch now to find out. Host-Directed Therapy, Tuberculosis Debate, MDR-TB Treatment, Mycobacterium tuberculosis, Precision Medicine 2024, Immunotherapy for TB. TFEB Master Regulator, Autophagy Induction, MNC1 Cells, Metformin for TB, SMIP-031, Inhalable TB drugs, Lung Fibrosis Prevention, PPM1A inhibitor, Drug Repurposing. #Tuberculosis #StopTB #HostDirectedTherapy #MedicalDebate #Immunology #GlobalHealth #MDRTB #PrecisionMedicine #autophagy #mtor #Metformin #LungHealth #HDT